Viewing Study NCT05448820


Ignite Creation Date: 2025-12-25 @ 4:09 AM
Ignite Modification Date: 2025-12-26 @ 3:06 AM
Study NCT ID: NCT05448820
Status: UNKNOWN
Last Update Posted: 2023-09-21
First Post: 2022-06-28
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: YH001 Plus Envafolimab With or Without Doxorubicin in Patients With Advanced or Metastatic Sarcoma
Sponsor: Tracon Pharmaceuticals Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module